Please login to the form below

Not currently logged in
Email:
Password:

Wim Goemaere appointed CFO at Bone Therapeutics

He joins from agricultural biotech firm Devgen

Wim Goemaere, Bone TherapeuticBone Therapeutics yesterday announced that Wim Goemaere is to join the company as chief financial officer.

Goemaere joins the biopharma company, which specialises in developing cell therapies for bone disorders, from Belgian agricultural biotech company Devgen, where he was also chief financial officer.

He spent five years in his role at Devgen, during which time he was involved in the takeover of the company by Syngenta for €403m.

Prior to this position, Goemaere was chief financial officer of Flanders Institute for Biotechnology, supporting the growth of the organisation into a leading research body. He also has experience at BP.

“His extensive experience of both the financial and biopharmaceutical sectors will be invaluable to the company as we progress to the next stage of our development,” commented Enrico Bastianelli, CEO of Bone Therapeutics.

This growth centres around the development of the company's lead product Preob, which is in phase III trials for the treatment of osteonecrosis and non-union fractures.

Bone Therapeutics is also developing an allogeneic bone cell therapy product called allob.

18th September 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...